Old Web
English
Sign In
Acemap
>
authorDetail
>
Delores Lindh
Delores Lindh
Antibody
Conjugate
Calicheamicin
Chemistry
Biochemistry
4
Papers
753
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An Anti-MUC1 Antibody−Calicheamicin Conjugate for Treatment of Solid Tumors. Choice of Linker and Overcoming Drug Resistance
2005
Bioconjugate Chemistry
Philip Ross Hamann
Lois Hinman
Carl Beyer
Lee M. Greenberger
Clara Lin
Delores Lindh
Ana T. Menendez
Rosalyn Wallace
Frederick E. Durr
Janis Upeslacis
Show All
Source
Cite
Save
Citations (64)
A Calicheamicin Conjugate with a Fully Humanized Anti-MUC1 Antibody Shows Potent Antitumor Effects in Breast and Ovarian Tumor Xenografts
2005
Bioconjugate Chemistry
Philip Ross Hamann
Lois Hinman
Carl F. Beyer
Delores Lindh
Janis Upeslacis
Dan Shochat
Andrew Mountain
Show All
Source
Cite
Save
Citations (44)
Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia.
2002
Bioconjugate Chemistry
Philip Ross Hamann
Lois Hinman
Irwin Hollander
Carl F. Beyer
Delores Lindh
Ryan Holcomb
William Hallett
Hwei Ru. Tsou
Janis Upeslacis
Dan Shochat
Andrew Mountain
David Flowers
Irwin D. Bernstein
Show All
Source
Cite
Save
Citations (451)
An Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia. Choice of Linker
2002
Bioconjugate Chemistry
Philip Ross Hamann
Lois Hinman
Carl F. Beyer
Delores Lindh
Janis Upeslacis
David Flowers
Irwin D. Bernstein
Show All
Source
Cite
Save
Citations (194)
1